Blastic vs Lytic Metastases¶

Overview¶

Vertebral metastases are broadly classified by their effect on bone as lytic (bone-destroying), blastic (bone-forming/sclerotic), or mixed. The pattern reflects the balance between osteoclastic (resorptive) and osteoblastic (formative) activity induced by the tumor and has implications for imaging detection, fracture risk, and differential diagnosis.

Lytic Metastases¶

Lytic metastases cause bone destruction through osteoclast activation. They appear as areas of decreased bone density with cortical disruption.

Common primary tumors: Lung, kidney (renal cell carcinoma), thyroid, hepatocellular carcinoma, melanoma

Imaging:

CT — Focal areas of bone destruction with loss of cortical integrity. Low attenuation compared to normal bone.
MRI — Low T1 signal (marrow replacement), high T2/STIR signal, enhancement on post-contrast images
Radiography — Lucent lesions; require approximately 30–50% trabecular bone loss before becoming visible
Bone scan — May be falsely negative ("cold" lesions) because lytic metastases may lack sufficient osteoblastic activity to concentrate radiotracer. PET/CT is more sensitive for purely lytic disease.

Clinical significance: Higher fracture risk than blastic metastases due to structural weakening.

Blastic (Sclerotic) Metastases¶

Blastic metastases stimulate osteoblast activity, producing dense, sclerotic bone formation.

Common primary tumors: Prostate (most classic), breast, carcinoid, medulloblastoma, transitional cell carcinoma (bladder)

Imaging:

CT — Dense, sclerotic foci within the vertebral body. High attenuation.
MRI — Low signal on both T1 AND T2 (dense bone produces signal void). May be less conspicuous on MRI than lytic metastases.
Radiography — Dense, white foci (ivory vertebra pattern if entire body is involved)
Bone scan — Intensely positive ("hot spots") due to active bone formation

Clinical significance: Lower fracture risk than lytic lesions but still structurally compromised. The "ivory vertebra" (uniformly dense vertebral body) has a differential: Paget disease, lymphoma, and blastic metastasis (most commonly prostate).

Mixed Metastases¶

Mixed lytic and blastic components within the same lesion or different lesions in the same patient.

Common primary tumors: Breast (most common cause of mixed pattern), lung, gastrointestinal

Differential Diagnosis of the Ivory Vertebra¶

Diagnosis	Key distinguishing features
Blastic metastasis (prostate)	Multiple levels, known primary, pedicle involvement
Paget disease	Vertebral body enlargement, thickened cortex, "picture frame" appearance
Lymphoma	May involve posterior elements, soft tissue mass, younger patient

Clinical Pearl

Purely lytic metastases (renal cell, thyroid, lung) may be missed on bone scintigraphy because they lack the osteoblastic response needed to concentrate radiotracer. PET/CT is significantly more sensitive for lytic disease. If a patient with known renal cell or thyroid carcinoma has a negative bone scan but clinical suspicion for metastases, PET/CT or whole-body MRI should be obtained.

Key Points¶

Lytic metastases are most common overall; prostate is the classic blastic primary
Lytic lesions have higher fracture risk and may be missed on bone scan
Blastic lesions are low signal on both T1 and T2 on MRI
Breast cancer is the most common cause of mixed lytic-blastic metastases
The ivory vertebra differential includes blastic metastasis, Paget disease, and lymphoma
PET/CT is more sensitive than bone scan for lytic metastases

References¶

Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3263660/
Reddington JA, Mendez GA, Ching A, Kubicky CD, Klimo P Jr, Ragel BT. Imaging characteristic analysis of metastatic spine lesions from breast, prostate, lung, and renal cell carcinomas for surgical planning: osteolytic versus osteoblastic. Surg Neurol Int. 2016;7(Suppl 13):S361–S365. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4879848/
Braun RA, Milito CFRB, Goldman SM, Fernandes EA. Ivory vertebra: imaging findings in different diagnoses. Radiol Bras. 2016;49(2):117–121. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4851483/
Graham TS. The ivory vertebra sign. Radiology. 2005;235(2):614–615. Available from: https://pubmed.ncbi.nlm.nih.gov/15858100/
Böker SM, Adams LC, Bender YY, Fahlenkamp UL, Wagner M, Hamm B, Makowski MR. Differentiation of predominantly osteoblastic and osteolytic spine metastases by using susceptibility-weighted MRI. Radiology. 2019;290(1):146–154. Available from: https://pubmed.ncbi.nlm.nih.gov/30375926/
Gaillard F, et al. Ivory vertebra. Radiopaedia.org. Available from: https://radiopaedia.org/articles/ivory-vertebra-1
Gaillard F, et al. Lytic bone metastases. Radiopaedia.org. Available from: https://radiopaedia.org/articles/lytic-bone-metastases-1